-
Subject Areas on Research
-
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
-
2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee.
-
A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation.
-
A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis.
-
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.
-
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.
-
A Machine Without an Owner's Manual.
-
A Minimally Invasive Approach to HeartMate 3 Implantation for Systemic Ventricular Failure Following the Mustard Procedure for Transposition of the Great Arteries.
-
A Multicenter Trial of a Shared Decision Support Intervention for Patients and Their Caregivers Offered Destination Therapy for Advanced Heart Failure: DECIDE-LVAD: Rationale, Design, and Pilot Data.
-
A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective.
-
A Standardized and Regionalized Network of Care for Cardiogenic Shock.
-
A contemporary review of mechanical circulatory support.
-
A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's disease.
-
A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database.
-
A global ranking approach to end points in trials of mechanical circulatory support devices.
-
A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy.
-
A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial.
-
A novel link between G6PD deficiency and hemolysis in patients with continuous-flow left ventricular assist devices.
-
A tale of two centrifugal left ventricular assist devices.
-
A team-based approach to patients in cardiogenic shock.
-
ABO Blood Group and Transfusions In the Intraoperative and Postoperative Period After LVAD Implantation.
-
Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
-
Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.
-
Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology.
-
Acute fulminant myocarditis: long-term follow-up after circulatory support with left ventricular assist device.
-
Acute kidney injury and 1-year mortality after left ventricular assist device implantation.
-
Advanced Heart Failure: Epidemiology, Diagnosis, and Therapeutic Approaches.
-
Advanced heart failure treated with continuous-flow left ventricular assist device.
-
Advanced therapies for end-stage heart failure.
-
Advances in the surgical treatment of heart failure.
-
Adverse events in the use of HeartMate vented electric and Novacor left ventricular assist devices: comparing apples and oranges.
-
After-hour ventricular assist device coverage: what level of expertise is required?
-
Algorithm for the diagnosis and management of suspected pump thrombus.
-
Allosensitization in cardiac transplantation: shooting at a moving target.
-
American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support.
-
American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support.
-
Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device.
-
Anesthetic management of the patient with a ventricular assist device.
-
Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices.
-
Antithrombotic Strategies and Device Thrombosis.
-
Aortic Insufficiency During Contemporary Left Ventricular Assist Device Support: Analysis of the INTERMACS Registry.
-
Aortic Valve Thrombus in a Patient With an Extracorporeal Left Ventricular Assist Device: The Dilemma of Management.
-
Aortic valve ring annuloplasty is an option in left ventricular assist device patients.
-
Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee.
-
Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.
-
Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation.
-
Assessing Frailty in Patients Undergoing Destination Therapy Left Ventricular Assist Device: Observations from Interagency Registry for Mechanically Assisted Circulatory Support.
-
Associated factors and clinical outcomes in mechanical circulatory support use in patients undergoing high risk on-pump cardiac surgery: Insights from the LEVO-CTS trial.
-
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
-
Associations of Preimplant Red Blood Cell Distribution Width with Clinical Outcomes Among Individuals with Left Ventricular Assist Devices.
-
Attitudes and Beliefs of Patients With Left-Ventricular Assist Devices Toward COVID-19 Vaccination and Willingness to Seek Care During the Pandemic.
-
BVS5000 support after cardiac transplantation.
-
Balancing Bleeding and Clotting: The Known Unknowns of Mechanically Assisted Circulation.
-
Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device.
-
Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale.
-
Biomarkers in Advanced Heart Failure: Implications for Managing Patients With Mechanical Circulatory Support and Cardiac Transplantation.
-
Biventricular Support With Intracorporeal, Continuous Flow, Centrifugal Ventricular Assist Devices.
-
Bleeding and thrombosis associated with ventricular assist device therapy.
-
Bleeding complications and blood product utilization with left ventricular assist device implantation.
-
Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients.
-
Bloodless HeartMate 3 explantation and orthotopic heart transplant in a heart failure patient refusing blood products.
-
Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: Epidemiology, risk factors, and mortality.
-
Bridge to long-term mechanical circulatory support with a left ventricular assist device: novel use of transcatheter aortic valve replacement.
-
Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes.
-
C-Reactive Protein Levels Predict Outcomes in Continuous-Flow Left Ventricular Assist Device Patients: An INTERMACS Analysis.
-
Can we prevent infections in patients with left ventricular assist devices?
-
Cangrelor use prior to left ventricular assist device surgery: a case series.
-
Cannulation strategy for centrifugal-flow ventricular assist device implantation late after arterial switch operation.
-
Capnocytophagia canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist system.
-
Cardiac Index Declines During Long-Term Left Ventricular Device Support.
-
Cardiac Rehabilitation After Ventricular Assist Device Implantation: A Worthwhile Exercise?
-
Cardiac computed tomography improves the identification of cardiomechanical complications among patients with suspected left ventricular assist device malfunction.
-
Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections.
-
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.
-
Cardiothoracic Morphology Measures in Heart Failure Patients to Inform Device Designs.
-
Cardiovascular Implantable Electronic Device Surgery Following Left Ventricular Assist Device Implantation.
-
Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVAL.
-
Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial.
-
Cataract surgery in patients with left ventricular assist devices.
-
Cerebral blood flow autoregulation is preserved after continuous-flow left ventricular assist device implantation.
-
Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy.
-
Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring.
-
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support.
-
Characteristics of strokes associated with centrifugal flow left ventricular assist devices.
-
Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
-
Clinical Characteristics and Outcomes of Patients With Myocardial Infarction and Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Data From The Society of Thoracic Surgeons National Database.
-
Clinical Experience of HeartMate II to HeartWare Left Ventricular Assist Device Exchange: A Multicenter Experience.
-
Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial.
-
Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry.
-
Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation.
-
Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure.
-
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.
-
Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era.
-
Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures.
-
Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study.
-
Clinical pharmacology considerations for children supported with ventricular assist devices.
-
Combined Therapy of Ventricular Assist Device and Membrane Oxygenator for Profound Acute Cardiopulmonary Failure.
-
Commentary: Managing the native heart in patients supported with durable left ventricular assist devices.
-
Commentary: Shunted single-ventricle neonatal ventricular-assist device support: Are we nearing a consensus strategy?
-
Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study.
-
Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients.
-
Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow.
-
Complete LVOT obstruction following aortic valve replacement after HeartMate II implantation.
-
Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device.
-
Computed tomography angiogram for left ventricular assist device thrombosis: When does it help?
-
Concomitant Thoracic Aortobifemoral Bypass With Left Ventricular Assist Device Implantation.
-
Concomitant tricuspid valve surgery during implantation of continuous-flow left ventricular assist devices: a Society of Thoracic Surgeons database analysis.
-
Consensus Statement: Hemostasis Trial Outcomes in Cardiac Surgery and Mechanical Support.
-
Contemporary Nationwide Heart Transplantation and Left Ventricular Assist Device Outcomes in Patients with Histories of Bariatric Surgery.
-
Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.
-
Controlling axillary intra-aortic balloon pump inflation is a viable option for turning an acute heart failure patient into a chronic one.
-
Controversies and Challenges of Ventricular Assist Device Therapy.
-
Cost of ventricular assist devices: can we afford the progress?
-
Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
-
Critical Care Transport of the Temporary Portable Ventricular Support Device.
-
Critically appraising the 2018 United Network for Organ Sharing donor allocation policy: adding life boats or rearranging the deck chairs?
-
Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge Trial.
-
Decoding the noncoding transcripts in human heart failure.
-
Defining Optimal Outcomes in Patients with Left Ventricular Assist Devices.
-
Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case-control study.
-
Development of a Pediatric Cardiac Mechanical Support Program.
-
Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review.
-
Different Strokes for Different Folks.
-
Differential gene expression and genomic patient stratification following left ventricular assist device support.
-
Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart Failure.
-
Disparities in access to left ventricular assist device therapy.
-
Does Guideline-Directed Medical Therapy for Heart Failure Offer Benefits After LVAD Placement?-A Call for a Randomized Clinical Trial.
-
Doing the wrong thing for the right reasons: The demise of the HVAD.
-
Driveline Infection Risk with Utilization of a Temporary External Anchoring Suture After Implantation of a Left Ventricular Assist Device.
-
Durability and Efficacy of Tricuspid Valve Repair in Patients Undergoing Left Ventricular Assist Device Implantation.
-
Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device.
-
Durable mechanical circulatory support devices.
-
Dysphagia in the setting of left ventricular assist device hemolysis.
-
EC-VAD: Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device.
-
ECMO and the Intraaortic Balloon Pump: In Search of the Ideal Mechanical Circulatory Support Device.
-
ECMO as a Bridge to Left Ventricular Assist Device or Heart Transplantation.
-
Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study.
-
Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
-
Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device.
-
Echocardiography in the Management of Patients with Left Ventricular Assist Devices: Recommendations from the American Society of Echocardiography.
-
Editorial Commentary: Determining the cost-effectiveness of mechanical circulatory support.
-
Educating Resident and Fellow Physicians on the Ethics of Mechanical Circulatory Support.
-
Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation.
-
Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock.
-
Effect of Heart Rate Reserve on Exercise Capacity in Patients Treated with a Continuous Left Ventricular Assist Device.
-
Effect of Socioeconomic Status on Patients Supported with Contemporary Left Ventricular Assist Devices.
-
Effect of age on outcomes after left ventricular assist device placement.
-
Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study.
-
Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
-
Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial.
-
Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury.
-
Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices.
-
Electrical storm in patients with left ventricular assist devices: Risk factors, incidence, and impact on survival.
-
Endovascular stent grafting of a left ventricular assist device outflow graft pseudoaneurysm.
-
Enrollment in Heart Failure Clinical Trials: Insights Into Which Entry Criteria Exclude Patients.
-
Epidemiology of infection in mechanical circulatory support: A global analysis from the ISHLT Mechanically Assisted Circulatory Support Registry.
-
Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.
-
Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association.
-
Evaluation of risk indices in continuous-flow left ventricular assist device patients.
-
Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review.
-
Exercise blood pressure response during assisted circulatory support: comparison of the total artificial [corrected] heart with a left ventricular assist device during rehabilitation.
-
Exploring differences between patients who accept, decline, and are deemed ineligible for left ventricular assist device implantation as destination therapy.
-
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
-
First successful bridge to cardiac transplantation using direct mechanical ventricular actuation.
-
First-in-human experience with Aortix intraaortic pump.
-
Functional status in left ventricular assist device-supported patients: a literature review.
-
Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device.
-
Glenn shunt facilitated weaning of right ventricular mechanical support.
-
HVAD: The ENDURANCE Supplemental Trial.
-
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
-
Heart Sound Analysis in Individuals Supported With Left Ventricular Assist Devices.
-
Heart Transplantation After HeartMate 3 Use Shortens Hospitalization but Might Impose Increased Risk of Rejection.
-
Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
-
HeartMate XVE malfunction caused by fluid aspiration into the vent port.
-
HeartMate® II continuous-flow left ventricular assist system.
-
Heartmate III Replacement for Recurring Left Ventricular Assist Device Pump Thrombosis.
-
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
-
Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
-
High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.
-
Highlights of the 2010 scientific sessions of the Heart Failure Society of America, San Diego, California, September 12-15, 2010.
-
Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
-
INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
-
INTERMACS: interval analysis of registry data.
-
Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices.
-
Identification of Severe Mitral Stenosis Using Real-Time Three-Dimensional Transesophageal Echocardiography During an Left Ventricular Assist Device Insertion.
-
Imaging for Temporary Mechanical Circulatory Support Devices.
-
Impact of Atrial Fibrillation on In-Hospital Mortality and Thromboembolic Complications after Left Ventricular Assist Device Implantation.
-
Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
-
Impact of Continuous Flow Left Ventricular Assist Device Therapy on Chronic Kidney Disease: A Longitudinal Multicenter Study.
-
Impact of Induction Immunosuppression on Post-Transplant Outcomes of Patients Bridged with Contemporary Left Ventricular Assist Devices.
-
Impact of Obesity on Ventricular Assist Device Outcomes.
-
Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial.
-
Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
-
Impact of heart failure drug therapy on rates of gastrointestinal bleeding in LVAD recipients: An INTERMACS analysis.
-
Impact of left ventricular assist device bridging on posttransplant outcomes.
-
Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices.
-
Impella Mechanical Circulatory Support for Takotsubo Syndrome With Shock: A Retrospective Multicenter Analysis.
-
Impella Placement in a Patient With d-Transposition of the Great Arteries After Mustard Procedure.
-
Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis.
-
Implantable Cardioverter-Defibrillators in Patients With Left Ventricular Assist Devices: On Trial and in Need of a Trial.
-
Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.
-
Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
-
Implantation of a HeartMate 3 ventricular assist device in a 21-kg pediatric patient with Fontan failure.
-
Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock.
-
Improved early survival with a nonsternotomy approach for continuous-flow left ventricular assist device replacement.
-
Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
-
Improving Value-Based Care for Left Ventricular Assist Device Therapy: Lowering Costs When Stakes Are High.
-
Incidence and Diagnostic Challenges of Bowel Ischemia after Continuous-flow Left Ventricular Assist Device Therapy.
-
Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation.
-
Incidence, Management, and Outcomes of Trauma in Patients with a Left Ventricular Assist Device in North Carolina.
-
Increased Opportunities for Transplantation for Women in the New Heart Allocation System.
-
Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999.
-
Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure.
-
Indications and Outcomes for Temporary Mechanical Circulatory Support in Pediatric Patients with Cardiac Failure.
-
Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation.
-
Inhaled Desmopressin for Refractory Gastrointestinal Bleeding in a Patient With a HeartMate II Left Ventricular Assist Device.
-
Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial.
-
Initial Experience of Left Ventricular Assist Device Support for Adult Patients with Transposition of the Great Vessels.
-
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
-
Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry.
-
Intra-aortic balloon pump trials: questions, answers, and unresolved issues.
-
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial.
-
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure.
-
Is it Time to Get More Aggressive With Aortic Valve Insufficiency During LVAD Implantation?
-
LVAD Outflow Graft Role in Pump Thrombosis.
-
Lead Extraction for Cardiovascular Implantable Electronic Device Infection in Patients With Left Ventricular Assist Devices.
-
Lead one ratio in left bundle branch block predicts poor cardiac resynchronization therapy response.
-
Left Ventricular Assist Devices: A Primer For the General Cardiologist.
-
Left Ventricular Support for the Management of Cardiogenic Shock: Sooner May Be Better.
-
Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations.
-
Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy.
-
Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
-
Left ventricular assist device effects on metabolic substrates in the failing heart.
-
Left ventricular assist device failure due to outflow graft compression by thrombofibrotic exudate.
-
Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.
-
Left ventricular assist devices as destination therapy for end-stage heart failure.
-
Left ventricular assist devices versus medical management in ambulatory heart failure patients: An analysis of INTERMACS Profiles 4 and 5 to 7 from the ROADMAP study.
-
Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
-
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
-
Load-independent analysis of a pulsatile right ventricular assist device.
-
Long-Term Neurocognitive Outcome in Patients With Continuous Flow Left Ventricular Assist Device.
-
Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device.
-
Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study.
-
Long-term follow-up of continuous flow left ventricular assist devices: complications and predisposing risk factors.
-
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries.
-
Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.
-
Low Blood Pressure Threshold for Adverse Outcomes During Left Ventricular Assist Device Support.
-
Low lead one ratio predicts clinical outcomes in left bundle branch block.
-
Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures.
-
Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.
-
Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading.
-
Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study.
-
Malpositioned left ventricular assist device cannula: diagnosis and management with transesophageal echocardiography guidance.
-
Management of Patients With Left Ventricular Assist Devices Requiring Teeth Extraction: Is Halting Anticoagulation Appropriate?
-
Management of cardiogenic shock complicating myocardial infarction: an update 2019.
-
Management of cardiogenic shock.
-
Management of epistaxis in patients with ventricular assist device: a retrospective review.
-
Management of pediatric tachyarrhythmias on mechanical support.
-
Management of primary graft failure after heart transplantation: Preoperative risks, perioperative events, and postoperative decisions.
-
Managing VAD Complications: Our Growth Industry.
-
Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation.
-
Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
-
Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy.
-
Mechanical unloading promotes myocardial energy recovery in human heart failure.
-
Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congential heart disease.
-
Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices.
-
Medical Management of Patients With a Left Ventricular Assist Device for the Non-Left Ventricular Assist Device Specialist.
-
Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices.
-
Migration of Intraaortic Balloon Pump Placed Via the Axillary Artery.
-
Mitral Intervention with LVAD: Preparing for Recovery.
-
Multimodal analgesia using opioid-sparing regimen in patients undergoing left ventricular assist device implantation.
-
Mustard Baffle Revision With Systemic Ventricular Assist Device Placement.
-
My approach to evaluation of patients prior to high-risk PCI with left ventricular support devices.
-
Myocardial scar in sarcoidosis by 12-lead ECG and pathology.
-
Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
-
Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices.
-
Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
-
Non-Vitamin K Antagonists Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Valves: A Systematic Review and Meta-Analysis.
-
Nonpharmacologic therapy in heart failure: an overview.
-
Novel Acoustic Biomarker of Quality of Life in Left Ventricular Assist Device Recipients.
-
Novel approaches to clinical trials: device-related infections.
-
Obesity and Outcomes Following Cardiogenic Shock Requiring Acute Mechanical Circulatory Support.
-
Old Device, New Tricks: Exploring Axillary Intra-Aortic Balloon Pump Use in Advanced Heart Failure.
-
One-and-done: Do left ventricular assist device patients on the transplant list really need frequent right heart catheterization assessments for pulmonary hypertension?
-
Operating in the Dark: When Is Surgery Necessary for Left Ventricular Assist Device Hemolysis?
-
OptiVol for Volume Assessment in Patients With Continuous Flow Left Ventricular Assist Device.
-
Optimal Bridging Strategy Post-Ventricular Assist Device Implantation Remains Unclear.
-
Optimism, Pessimism, and Pragmatism: Musings on the Cost of Medical Innovation.
-
Orthostatic Hypotension in Patients With Left Ventricular Assist Devices: Acquired Autonomic Dysfunction.
-
Outcomes After Extracorporeal Right Ventricular Assist Device Combined With Durable Left Ventricular Assist Device Support.
-
Outcomes Among Patients Transferred for Revascularization With Impella for Acute Myocardial Infarction With Cardiogenic Shock from the cVAD Registry.
-
Outcomes after implantable left ventricular assist device replacement procedures.
-
Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure.
-
Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation.
-
Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.
-
Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device.
-
Outcomes of Laparoscopic Cholecystectomy in Patients Supported with a Left Ventricular Assist Device.
-
Outcomes of Severely Obese Patients Supported by a Centrifugal-Flow Left Ventricular Assist Device.
-
Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
-
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
-
Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry.
-
PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.
-
PREVENTion of non-surgical bleeding by management of HeartMate II patients without anti-platelet therapy (PREVENT II) trial.
-
PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study.
-
Paediatric cardiomyopathy and anaesthesia.
-
Part II: Sealing holes in the safety net.
-
Patient selection for left ventricular assist devices.
-
Patient selection for mechanical circulatory support.
-
Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management).
-
Percutaneous Intervention for Left Ventricular Assist Device Outflow Obstruction.
-
Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
-
Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics.
-
Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial.
-
Pericardial Adipose Tissue Volume and Left Ventricular Assist Device-Associated Outcomes.
-
Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center.
-
Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis.
-
Physiological and Psychological Stress in Patients Living With a Left Ventricular Assist Device.
-
Pilot investigation of a novel testing strategy for bleeding in ventricular assist device recipients.
-
Planned right ventricular support for combined heart-liver transplantation.
-
Plasma Levels of MicroRNA-155 Are Upregulated with Long-Term Left Ventricular Assist Device Support.
-
Point-of-Care Rapid-Seeding Ventricular Assist Device with Blood-Derived Endothelial Cells to Create a Living Antithrombotic Coating.
-
Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock.
-
Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure.
-
Post-Myocardial Infarction Heart Failure.
-
Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
-
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
-
Pre-operative atrial fibrillation and early right ventricular failure after left ventricular assist device implantation: a systematic review and meta-analysis.
-
Pre-operative proteinuria in left ventricular assist devices and clinical outcome.
-
Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
-
Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score.
-
Predictive capabilities of the European registry for patients with mechanical circulatory support right-sided heart failure risk score after left ventricular assist device implantation.
-
Predictors of Warfarin Time in Therapeutic Range after Continuous-Flow Left Ventricular Assist Device.
-
Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy.
-
Preparedness planning before mechanical circulatory support: a "how-to" guide for palliative medicine clinicians.
-
Presentation and management of left ventricular assist device inflow cannula malposition.
-
Prognostic Impact of Pulmonary Artery Pulsatility Index (PAPi) in Patients With Advanced Heart Failure: Insights From the ESCAPE Trial.
-
Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.
-
Prognostic Value of Peak Oxygen Uptake in Patients Supported With Left Ventricular Assist Devices (PRO-VAD).
-
Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement.
-
Progression of aortic valve insufficiency during centrifugal versus axial flow left ventricular assist device support.
-
Psychosocial Risk and Its Association With Outcomes in Continuous-Flow Left Ventricular Assist Device Patients.
-
Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality.
-
Pump speed modulations and sub-maximal exercise tolerance in left ventricular assist device recipients: A double-blind, randomized trial.
-
Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry.
-
Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation.
-
Quality of life and treatment preference for ventricular assist device therapy in ambulatory advanced heart failure: A report from the REVIVAL study.
-
RAAS Inhibition to Prevent GI Bleeding: Another Reason to Do the Right Thing.
-
Ramp Study Hemodynamics, Functional Capacity, and Outcome in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices.
-
Ramping up evidence-based ventricular assist device care.
-
Re: Desmopressin Use in Refractory Gastrointestinal Bleeding in LVAD Patient.
-
Recent advances in porcine cardiac xenotransplantation: from aortic valve replacement to heart transplantation.
-
Recovery of left ventricular function is associated with improved outcomes in LVAD recipients.
-
Recurrence of cardiac sarcoidosis in a heart transplant recipient.
-
Recurrence of heart failure symptoms after LVAD placement due to bradycardia-induced inflow obstruction.
-
Red Cell Distribution Width Predicts 90 Day Mortality in Continuous-Flow Left Ventricular Assist Device Patients.
-
Reducing ECG Artifact From Left Ventricular Assist Device Electromagnetic Interference.
-
Relation between pressure and volume unloading during ramp testing in patients supported with a continuous-flow left ventricular assist device.
-
Relationship Between Electrical and Mechanical Dyssynchrony and Outcomes Among Patients Undergoing Cardiac Resynchronization Therapy.
-
Relationship between renal function and left ventricular assist device use.
-
Relationship of ventricular assist device support duration with pediatric heart transplant outcomes.
-
Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device.
-
Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
-
Replacement of continuous-flow left ventricular assist device via left subcostal incision.
-
Reply: Is Pump the Answer to Heart Failure With Preserved Ejection Fraction?
-
Reply: Temporary Mechanical Circulatory Support as a Bridge to Transplantation: Return of the Intra-Aortic Balloon Pump.
-
Residual Heart Failure on Mechanically Assisted Circulation: A Call to Action.
-
Residual mitral regurgitation in patients with left ventricular assist device support - An INTERMACS analysis.
-
Response by Truby and Topkara to Letter Regarding Article, "Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality: A Propensity-Matched Analysis of the United Network of Organ Sharing Database".
-
Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
-
Rethinking papillary muscle resection for refractory ventricular tachycardia in the LVAD era. A case report.
-
Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
-
Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis.
-
Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
-
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.
-
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
-
Risk Assessment in Patients with a Left Ventricular Assist Device Across INTERMACS Profiles Using Bayesian Analysis.
-
Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: design and rationale of the ROADMAP clinical trial.
-
Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
-
Risk factors for stroke on left ventricular assist devices.
-
Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation.
-
Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.
-
Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support.
-
Rotary pumps: new developments and future perspectives.
-
SSRI/SNRI Therapy is Associated With a Higher Risk of Gastrointestinal Bleeding in LVAD Patients.
-
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial.
-
Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study.
-
Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure.
-
Severe heart failure and mechanical circulatory support.
-
Sex-Based Differences in Left Ventricular Assist Device Utilization: Insights From the Nationwide Inpatient Sample 2004 to 2016.
-
Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation.
-
Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes.
-
Sharing the care of mechanical circulatory support: collaborative efforts of patients/caregivers, shared-care sites, and left ventricular assist device implanting centers.
-
Social Support Moderates the Relationship Between Perceived Stress and Quality of Life in Patients With a Left Ventricular Assist Device.
-
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States.
-
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States.
-
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States.
-
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary.
-
Strategies for Mechanical Right Ventricular Support During Left Ventricular Assist Device Implant.
-
Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices.
-
Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with a left ventricular assist device: A case series and systematic review.
-
Successful organ donation after long-term circulatory support with nonpulsatile mechanical support.
-
Surgical Technique for Replacement of Centrifugal Left Ventricular Assist Device Through a Left Thoracotomy.
-
Surgical correction of aortic valve insufficiency after left ventricular assist device implantation.
-
Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice.
-
Surgical management of Novacor drive-line exit site infections.
-
Surgical treatments for advanced heart failure.
-
Survival After Orthotopic Heart Transplantation in Patients Undergoing Bridge to Transplantation With the HeartWare HVAD Versus the Heartmate II.
-
Temporal changes in hospital costs for left ventricular assist device implantation.
-
Temporary extracorporeal left ventricular assist device support for implantable left ventricular assist device replacement cases.
-
The ABCs of managing systolic heart failure: Past, present, and future.
-
The Diagnostic Yield of Repeated Endoscopic Evaluation in Patients with Gastrointestinal Bleeding and Left Ventricular Assist Devices.
-
The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies.
-
The HeartMate 6.
-
The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device Implantation.
-
The Risk of Stroke on Left Ventricular Assist Device Support: Steady Gains or Stalled Progress?
-
The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2021 Update on Echocardiography.
-
The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial.
-
The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants.
-
The bispectral index in the diagnosis of perioperative stroke: a case report and discussion.
-
The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure.
-
The changing landscape of advanced heart failure therapeutics.
-
The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry.
-
The impact of race on utilization of durable left ventricular assist device therapy in patients with advanced heart failure.
-
The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device.
-
The role of heart failure pharmacotherapy after left ventricular assist device support.
-
The spectrum of complications following left ventricular assist device placement.
-
Thoratec VAD system as a bridge to heart transplantation.
-
Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices.
-
Thrombus around the redesigned HeartWare HVAD inflow cannula: A pathologic case series.
-
Thrombus on the inflow cannula of the HeartWare HVAD: an update.
-
Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Left Ventricular Assist Devices.
-
Toward a Self-Actuating Continuous Flow Ventricular Assist Device: The Pudding Is in the Proof.
-
Transapical ProtekDuo Rapid Deployment Cannula as Temporary Left Ventricular Assist Device in a Jehovah's Witness Patient.
-
Transcatheter aortic valve replacement performed via left ventricular assist device inflow cannula.
-
Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab.
-
Transplanting a heart with a persistent left superior vena cava.
-
Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States.
-
Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011.
-
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.
-
Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials.
-
Unexpected abrupt increase in left ventricular assist device thrombosis.
-
Unloading a Broken Heart: Impella Support for Takotsubo Syndrome Complicated by Cardiogenic Shock.
-
Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS.
-
Use of HeartWare Ventricular Assist System for systemic ventricular support of a pediatric patient after Mustard procedure.
-
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes.
-
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart.
-
Use of a continuous-flow device in patients awaiting heart transplantation.
-
Usefulness of 2 centrifugal ventricular assist devices in a total artificial heart configuration: A preliminary report.
-
Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices.
-
Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device.
-
Utilization of Implantable Cardioverter Defibrillators Among Patients with a Left Ventricular Assist Device: Insights From a National Database.
-
VA-ECMO for cardiogenic shock in the contemporary era of heart transplantation: Which patients should be urgently transplanted?
-
Valve-in-Ring Transcatheter Aortic Valve Replacement After Left Ventricular Assist Device Therapy.
-
Valvular heart disease in patients supported with left ventricular assist devices.
-
Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes.
-
Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II Left Ventricular Assist Device.
-
What If the Destination Is Transplant? Outcomes of Destination Therapy Patients Who Were Transplanted.
-
When VAD Things Happen to Good People.
-
When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
-
Who wants a left ventricular assist device for ambulatory heart failure? Early insights from the MEDAMACS screening pilot.
-
Working formulation for the standardization of definitions of infections in patients using ventricular assist devices.
-
Worldwide Experience of a Durable Centrifugal Flow Pump in Pediatric Patients.
-
iPhone in the Management of the Berlin Heart EXCOR Ventricular Assist Device.
-
Keywords of People
-
Mentz, Robert John,
Associate Professor of Medicine,
Medicine, Cardiology
-
Milano, Carmelo Alessio,
Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery,
Surgery, Cardiovascular and Thoracic Surgery
-
O'Connor, Christopher Michael,
Richard Sean Stack, M.D. Distinguished Professor,
Medicine, Clinical Pharmacology
-
Swaminathan, Madhav,
Professor of Anesthesiology,
Anesthesiology, Cardiothoracic